3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
4
Carcinoma, Renal Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Kidney Neoplasms
3
Pancreatic Neoplasms
2
Multiple Myeloma
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia
2
Warts
1
Small Cell Lung Carcinoma
1
Recurrence
1
Papilloma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Lung Neoplasms
1
HIV Infections
1
Colorectal Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Cyclophosphamide
18
Trastuzumab
16
Paclitaxel
15
Taxes
11
Doxorubicin
11
Radiotherapy
7
Lapatinib
6
Albumin-Bound Paclitaxel
6
Vorinostat
5
Tamoxifen
5
Docetaxel
5
Carboplatin
5
Capecitabine
5
Bevacizumab
5
Radiation
4
Letrozole
4
Immunohistochemistry
4
Anastrozole
4
sargramostim
3
pegfilgrastim
3
exemestane
3
Magnetic Resonance Spectroscopy
3
Immunoenzyme Techniques
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Granulocyte Colony-Stimulating Factor
3
Fluorodeoxyglucose F18
3
Flow Cytometry
3
Filgrastim
3
Chemotherapy, Adjuvant
3
saponin QA-21V1
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Neoplasms, Male
×
Interferon-alpha
×
Clear all
No trials found.